Deep Remission Tied to RA Control - Takeaways - MDSpire

Deep Remission Tied to RA Control

At 5 years, 63% of patients in the CliDR group maintained sustained remission compared with 38% in the non-CliDR group.

  • By

  • Andrea Surnit

  • May 6, 2026

  • 4 min

Share

  • 1

    Patients with rheumatoid arthritis achieving clinical deep remission (CliDR) maintain long-term remission better than those meeting less stringent criteria.

  • 2

    In a study of 145 patients, 63% in the CliDR group maintained sustained remission at 5 years, compared to 38% in the non-CliDR group.

  • 3

    Relapse rates were significantly lower in the CliDR group, with only 12 relapses compared to 70 in the non-CliDR group.

  • 4

    Tapering treatment increased relapse risk 8.5-fold in non-CliDR patients, while the risk was significantly lower in the CliDR group.

  • 5

    The study highlights that deeper remission may offer better prognostic information for treatment tapering decisions in rheumatoid arthritis.

Original Source(s)

Deep Remission Tied to RA Control

  • by Andrea Surnit

  • May 6, 2026

Related Content

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

Hair Repigmentation Reported With Baricitinib in Canities Subita

A single case suggests a possible benefit, but confounding factors and the off-label setting temper the conclusions.

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.